Listed
Stock Code: 337840
| Company Name | 주식회사 유엑스엔 |
| English Name | UXN Co., Ltd. |
| Business Reg. No. | 1448101346 |
| CEO | 박세진 |
| Address | 경기도 의왕시 오봉산단3로 25 경기도 의왕시 오봉산단3로 25, 1동 505호(삼동, 의왕테크노파크) |
| Industry | 전기식 진단 및 요법 기기 제조업 |
| Industry Code | 27112 |
| Main Products | CGMS (연속혈당측정기) |
| Established | 20120517 |
| Phone | 02-858-0931 |
| Website | uxn.co.kr |
| Regular Employees | 35persons |
| Corp. Reg. No. | 1311110312428 |
Venture Certified
| 기술평가보증기업(기금) | 2012-09-17 ~ 2014-09-16 | 20120107757 | 2012-09-17 |
| 벤처투자유형 | 2019-03-14 ~ 2021-03-13 | 20190300227 | 2012-09-17 |
| 벤처투자유형 | 2021-08-04 ~ 2024-08-03 | 20210804010092 | 2012-09-17 |
| 벤처투자유형 | 2024-08-04 ~ 2027-08-03 | 20240709010036 | 2012-09-17 |
Revenue CAGR +118.7%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 5.1B | 3.4B | 1.1B |
| Operating Profit | -58B | -68B | -60B |
| Net Profit | -3.3B | -140B | -31B |
| Total Assets | 299B | 334B | 389B |
| Total Liabilities | 419B | 472B | 408B |
| Total Equity | -120B | -138B | -19B |
Capital Erosion: Total equity is negative or below 50% of capital stock
Operating Loss: Op. profit -58B
3 Consecutive Years of Net Loss
▲ 131.4%
▲ 9.3%
▲ 70.2%
▲ 72.4%
▼ 98.0%
| Name | Position | Role | Comp. (M KRW) |
|---|---|---|---|
| 박세진 | 사내이사 | 경영총괄 | - |
| 강선길 | 사내이사 | 연구총괄 | - |
| 민선홍 | 기타비상무이사 | 기타비상무이사 | - |
| 권용준 | 감사 | 감사 | - |
| 박준영 | 미등기 | 생산기술 /제조총괄 | - |
| 조찬호 | 미등기 | 경영/자금총괄 | - |
| 김정현 | 미등기 | 연구개발/바이오전자 | - |
| Shareholder | Ownership (%) | Shares Held |
|---|---|---|
| - | ||
| - | ||
| - | ||
| - |
| Regular Employees | 35persons |
| CEO | 박세진 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "경기도 의왕시",
"ceo_name": "박세진",
"certificate": [
{
"cert_number": "20120107757",
"changes": "",
"disclosure_date": "2012-09-17",
"first_cert_date": "2012-09-17",
"no": "1",
"type": "기술평가보증기업(기금)",
"valid_period": "2012-09-17 ~ 2014-09-16"
},
{
"cert_number": "20190300227",
"changes": "",
"disclosure_date": "2019-03-14",
"first_cert_date": "2012-09-17",
"no": "2",
"type": "벤처투자유형",
"valid_period": "2019-03-14 ~ 2021-03-13"
},
{
"cert_number": "20210804010092",
"changes": "",
"disclosure_date": "2021-08-04",
"first_cert_date": "2012-09-17",
"no": "3",
"type": "벤처투자유형",
"valid_period": "2021-08-04 ~ 2024-08-03"
},
{
"cert_number": "20240709010036",
"changes": "",
"disclosure_date": "2024-07-09",
"first_cert_date": "2012-09-17",
"no": "4",
"type": "벤처투자유형",
"valid_period": "2024-08-04 ~ 2027-08-03"
}
],
"company_name": "주식회사 유엑스엔",
"corp_no": "131111-*******",
"financials": {
"2022": {
"capital_stock": 6236577000,
"cost_of_sales": 85805000,
"current_assets": 28316175000,
"current_liabilities": 20544954000,
"gross_profit": 21545000,
"net_income": -3118474000,
"net_income_bs": -3118474000,
"non_current_assets": 10577629000,
"non_current_liabilities": 20219063000,
"non_operating_expenses": 5722318000,
"non_operating_income": 8590781000,
"operating_profit": -5986937000,
"revenue": 107350000,
"sga_expenses": 6008482000,
"total_assets": 38893804000,
"total_equity": -1870213000,
"total_liabilities": 40764017000
},
"2023": {
"capital_stock": 7448577000,
"cost_of_sales": 118098000,
"current_assets": 25345093000,
"current_liabilities": 46125433000,
"gross_profit": 218392000,
"net_income": -14009326000,
"net_income_bs": -14009326000,
"non_current_assets": 8050888000,
"non_current_liabilities": 1053660000,
"non_operating_expenses": 8778624000,
"non_operating_income": 1577101000,
"operating_profit": -6807803000,
"revenue": 336490000,
"sga_expenses": 7026195000,
"total_assets": 33395981000,
"total_equity": -13783112000,
"total_liabilities": 47179093000
},
"2024": {
"capital_stock": 8985029000,
"cost_of_sales": 174137000,
"current_assets": 20278664000,
"current_liabilities": 41055640000,
"gross_profit": 339328000,
"net_income": -326882000,
"net_income_bs": -326882000,
"non_current_assets": 9579980000,
"non_current_liabilities": 818078000,
"non_operating_expenses": 2713680000,
"non_operating_income": 8191855000,
"operating_profit": -5805057000,
"revenue": 513465000,
"sga_expenses": 6144385000,
"total_assets": 29858644000,
"total_equity": -12015074000,
"total_liabilities": 41873718000
}
},
"industry": "전기식 진단 및 요법 기기 제조업",
"investment": [
{
"amount": "1,000,000,000",
"changes": "1,000,000,000",
"date": "2020-09-07"
},
{
"amount": "1,000,008,000",
"changes": "1,000,008,000",
"date": "2020-08-14"
},
{
"amount": "1,000,000,000",
"changes": "1,000,000,000",
"date": "2017-01-12"
}
],
"main_products": "CGMS (연속혈당측정기)",
"phone": "02-858-****",
"years": [
2024,
2023,
2022
]
}Data Quality: 4/10 | Primary Source: DART | Section Coverage: 8/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | DART | Collected |
| Financial Statements | Venture System | Collected |
| Investment Metrics | Venture System | Collected |
| Officers | DART | Collected |
| Employment | DART | Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| DART Financial | 2026-02-27 | Collected |
| G2B Procurement | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Cert. Info | 2026-02-25 | Collected |
| Venture System Detail | 2026-02-25 | Collected |